← BWX overview

BWX vs Parsons: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BWX Technologies Inc (BWXT)

Q3 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

August 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Latest
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Q2 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

Parsons Corp (PSN)

Q3 2026
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

July 2026
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

Latest
▲2▼2

Parsons Slashes 2026 Guidance, Triggers 38% Plunge and Investigations

  • 2026 Guidance Cut and Q2 Miss Parsons cut full-year 2026 revenue and profit guidance and reported a surprise net loss, sending shares down 38%. The company blamed divestitures and delayed awards, but investors fear weaker future earnings.

    This is the main new event that directly caused the stock to plummet and changes the earnings outlook.

  • Securities Investigations Launched Multiple law firms are investigating whether Parsons misled investors about its 2026 outlook. This adds legal uncertainty and could lead to fines or lawsuits, further pressuring the stock.

    New investigations are a direct consequence of the guidance cut and add a new risk factor for investors.

  • New Army Cyber Contract Parsons won a contract to provide cybersecurity for the U.S. Army Research Lab, deepening its role in high-value defense tech. This supports long-term revenue but is overshadowed by the guidance cut.

    This is a new positive development that shows underlying demand, but its impact is muted by the larger negative news.

  • Industrial Modernization Demand Parsons highlighted a $169.5M Army contract and growing demand for industrial base modernization. This shows a healthy pipeline, but near-term execution issues and guidance cut dominate investor sentiment.

    This new contract and demand signal are positive but not enough to offset the negative guidance revision.

Q2 2026
▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

June 2026
▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

▲4

Parsons Wins New Defense Contracts and Launches Biometrics Platform

  • New $245M Naval Research Lab Contract Parsons won a $245 million contract to support satellite ground systems for the U.S. Naval Research Laboratory over five years. This directly adds revenue and extends a 30-year relationship, giving investors more confidence in future earnings.

    This is a concrete new contract that directly boosts Parsons' revenue outlook.

  • AresNXT Biometrics Platform Launch Parsons launched AresNXT, a new biometrics platform for secure identity checks. It already has pilot use with a federal law enforcement client. New products can open new revenue streams and show Parsons is innovating, which supports the stock price.

    This is a new product launch that could drive future growth and shows innovation.

  • PFAS Remediation Expansion Parsons announced expansion of its PFAS cleanup services, with recent wins at military bases and major airports. This shows growing demand for its environmental services, which can lead to more contracts and revenue.

    This is a new business expansion that signals increased demand for Parsons' services.

  • Strong Demand for Cyber and Electromagnetic Capabilities Parsons highlighted strong government demand for its cyber and electromagnetic warfare solutions. While this is a general update, it reinforces that Parsons is well-positioned in a growing defense area, which supports long-term revenue growth.

    This points to ongoing demand in a key growth area for Parsons.

© 2026 MarketDXWhy